Jie Zheng1, Yuemiao Zhang2, Humaira Rasheed1,3, Venexia Walker1,4, Yuka Sugawara5, Jiachen Li6, Yue Leng7, Benjamin Elsworth1, Robyn E Wootton1, Si Fang1, Qian Yang1, Stephen Burgess8,9, Philip C Haycock1, Maria Carolina Borges1, Yoonsu Cho1, Rebecca Carnegie1, Amy Howell1, Jamie Robinson1, Laurent F Thomas3,10, Ben Michael Brumpton1,3,11, Kristian Hveem3, Stein Hallan10,12, Nora Franceschini13, Andrew P Morris14, Anna Köttgen15, Cristian Pattaro16, Matthias Wuttke15, Masayuki Yamamoto17, Naoki Kashihara18, Masato Akiyama19,20, Masahiro Kanai21,22, Koichi Matsuda23, Yoichiro Kamatani19,24, Yukinori Okada22,25,26, Robin Walters27, Iona Y Millwood27, Zhengming Chen27, George Davey Smith1,28, Sean Barbour29,30, Canqing Yu6, Bjørn Olav Åsvold3,31, Hong Zhang2, Tom R Gaunt1,28. 1. MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, UK. 2. Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, P. R. China. 3. K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. 4. Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 5. Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan. 6. Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, P. R. China. 7. Department of Psychiatry, University of California, San Francisco, CA, USA. 8. MRC Biostatistics Unit, Cambridge Institute of Public Health, Cambridge, UK. 9. Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. 10. Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. 11. Department of Thoracic Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. 12. Department of Nephrology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. 13. Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA. 14. Division of Musculoskeletal and Dermatological Sciences, University of Manchester, Manchester, UK. 15. Institute of Genetic Epidemiology, Department of Biometry, Epidemiology and Medical Bioinformatics, Faculty of Medicine and Medical Center-University of Freiburg, Freiburg, Germany. 16. Eurac Research, Institute for Biomedicine (affiliated with the University of Lübeck), Bolzano, Italy. 17. Tohoku Medical Megabank Organization and Tohoku University Graduate School of Medicine, Tohoku University, Sendai, Miyagi, Japan. 18. Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Okayama, Japan. 19. Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. 20. Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. 21. Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. 22. Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan. 23. Department of Computational Biology and Medical Sciences, Graduate school of Frontier Sciences, the University of Tokyo, Tokyo, Japan. 24. Laboratory of Complex Trait Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, the University of Tokyo, Tokyo, Japan. 25. Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Japan. 26. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Japan. 27. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. 28. NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol, UK. 29. Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada. 30. British Columbia Provincial Renal Agency, Vancouver, British Columbia, Canada. 31. Department of Endocrinology, Clinic of Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Abstract
BACKGROUND: This study was to systematically test whether previously reported risk factors for chronic kidney disease (CKD) are causally related to CKD in European and East Asian ancestries using Mendelian randomization. METHODS: A total of 45 risk factors with genetic data in European ancestry and 17 risk factors in East Asian participants were identified as exposures from PubMed. We defined the CKD by clinical diagnosis or by estimated glomerular filtration rate of <60 ml/min/1.73 m2. Ultimately, 51 672 CKD cases and 958 102 controls of European ancestry from CKDGen, UK Biobank and HUNT, and 13 093 CKD cases and 238 118 controls of East Asian ancestry from Biobank Japan, China Kadoorie Biobank and Japan-Kidney-Biobank/ToMMo were included. RESULTS: Eight risk factors showed reliable evidence of causal effects on CKD in Europeans, including genetically predicted body mass index (BMI), hypertension, systolic blood pressure, high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein(a), type 2 diabetes (T2D) and nephrolithiasis. In East Asians, BMI, T2D and nephrolithiasis showed evidence of causality on CKD. In two independent replication analyses, we observed that increased hypertension risk showed reliable evidence of a causal effect on increasing CKD risk in Europeans but in contrast showed a null effect in East Asians. Although liability to T2D showed consistent effects on CKD, the effects of glycaemic phenotypes on CKD were weak. Non-linear Mendelian randomization indicated a threshold relationship between genetically predicted BMI and CKD, with increased risk at BMI of >25 kg/m2. CONCLUSIONS: Eight cardiometabolic risk factors showed causal effects on CKD in Europeans and three of them showed causality in East Asians, providing insights into the design of future interventions to reduce the burden of CKD.
BACKGROUND: This study was to systematically test whether previously reported risk factors for chronic kidney disease (CKD) are causally related to CKD in European and East Asian ancestries using Mendelian randomization. METHODS: A total of 45 risk factors with genetic data in European ancestry and 17 risk factors in East Asian participants were identified as exposures from PubMed. We defined the CKD by clinical diagnosis or by estimated glomerular filtration rate of <60 ml/min/1.73 m2. Ultimately, 51 672 CKD cases and 958 102 controls of European ancestry from CKDGen, UK Biobank and HUNT, and 13 093 CKD cases and 238 118 controls of East Asian ancestry from Biobank Japan, China Kadoorie Biobank and Japan-Kidney-Biobank/ToMMo were included. RESULTS: Eight risk factors showed reliable evidence of causal effects on CKD in Europeans, including genetically predicted body mass index (BMI), hypertension, systolic blood pressure, high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein(a), type 2 diabetes (T2D) and nephrolithiasis. In East Asians, BMI, T2D and nephrolithiasis showed evidence of causality on CKD. In two independent replication analyses, we observed that increased hypertension risk showed reliable evidence of a causal effect on increasing CKD risk in Europeans but in contrast showed a null effect in East Asians. Although liability to T2D showed consistent effects on CKD, the effects of glycaemic phenotypes on CKD were weak. Non-linear Mendelian randomization indicated a threshold relationship between genetically predicted BMI and CKD, with increased risk at BMI of >25 kg/m2. CONCLUSIONS: Eight cardiometabolic risk factors showed causal effects on CKD in Europeans and three of them showed causality in East Asians, providing insights into the design of future interventions to reduce the burden of CKD.
Authors: Sankar D Navaneethan; Hans Yehnert; Fady Moustarah; Martin J Schreiber; Philip R Schauer; Srinivasan Beddhu Journal: Clin J Am Soc Nephrol Date: 2009-09-17 Impact factor: 8.237
Authors: Connor A Emdin; Amit V Khera; Pradeep Natarajan; Derek Klarin; Hong-Hee Won; Gina M Peloso; Nathan O Stitziel; Akihiro Nomura; Seyedeh M Zekavat; Alexander G Bick; Namrata Gupta; Rosanna Asselta; Stefano Duga; Piera Angelica Merlini; Adolfo Correa; Thorsten Kessler; James G Wilson; Matthew J Bown; Alistair S Hall; Peter S Braund; Nilesh J Samani; Heribert Schunkert; Jaume Marrugat; Roberto Elosua; Ruth McPherson; Martin Farrall; Hugh Watkins; Cristen Willer; Gonçalo R Abecasis; Janine F Felix; Ramachandran S Vasan; Eric Lander; Daniel J Rader; John Danesh; Diego Ardissino; Stacey Gabriel; Danish Saleheen; Sekar Kathiresan Journal: J Am Coll Cardiol Date: 2016-12-27 Impact factor: 24.094
Authors: N J Timpson; B G Nordestgaard; R M Harbord; J Zacho; T M Frayling; A Tybjærg-Hansen; G Davey Smith Journal: Int J Obes (Lond) Date: 2010-08-17 Impact factor: 5.095
Authors: Wei Zhou; Jonas B Nielsen; Lars G Fritsche; Rounak Dey; Maiken E Gabrielsen; Brooke N Wolford; Jonathon LeFaive; Peter VandeHaar; Sarah A Gagliano; Aliya Gifford; Lisa A Bastarache; Wei-Qi Wei; Joshua C Denny; Maoxuan Lin; Kristian Hveem; Hyun Min Kang; Goncalo R Abecasis; Cristen J Willer; Seunggeun Lee Journal: Nat Genet Date: 2018-08-13 Impact factor: 38.330
Authors: Daniel M Jordan; Hyon K Choi; Marie Verbanck; Ruth Topless; Hong-Hee Won; Girish Nadkarni; Tony R Merriman; Ron Do Journal: PLoS Med Date: 2019-01-15 Impact factor: 11.069
Authors: Andrew P Morris; Thu H Le; Haojia Wu; Artur Akbarov; Peter J van der Most; Gibran Hemani; George Davey Smith; Anubha Mahajan; Kyle J Gaulton; Girish N Nadkarni; Adan Valladares-Salgado; Niels Wacher-Rodarte; Josyf C Mychaleckyj; Nicole D Dueker; Xiuqing Guo; Yang Hai; Jeffrey Haessler; Yoichiro Kamatani; Adrienne M Stilp; Gu Zhu; James P Cook; Johan Ärnlöv; Susan H Blanton; Martin H de Borst; Erwin P Bottinger; Thomas A Buchanan; Sylvia Cechova; Fadi J Charchar; Pei-Lun Chu; Jeffrey Damman; James Eales; Ali G Gharavi; Vilmantas Giedraitis; Andrew C Heath; Eli Ipp; Krzysztof Kiryluk; Holly J Kramer; Michiaki Kubo; Anders Larsson; Cecilia M Lindgren; Yingchang Lu; Pamela A F Madden; Grant W Montgomery; George J Papanicolaou; Leslie J Raffel; Ralph L Sacco; Elena Sanchez; Holger Stark; Johan Sundstrom; Kent D Taylor; Anny H Xiang; Aleksandra Zivkovic; Lars Lind; Erik Ingelsson; Nicholas G Martin; John B Whitfield; Jianwen Cai; Cathy C Laurie; Yukinori Okada; Koichi Matsuda; Charles Kooperberg; Yii-Der Ida Chen; Tatjana Rundek; Stephen S Rich; Ruth J F Loos; Esteban J Parra; Miguel Cruz; Jerome I Rotter; Harold Snieder; Maciej Tomaszewski; Benjamin D Humphreys; Nora Franceschini Journal: Nat Commun Date: 2019-01-03 Impact factor: 14.919
Authors: Luyan Gao; Kun Wang; Qing-Bin Ni; Hongguang Fan; Lan Zhao; Lei Huang; Mingfeng Yang; Huanming Li Journal: Front Genet Date: 2022-02-11 Impact factor: 4.599
Authors: Julie Aarestrup; Kim Blond; Dorte Vistisen; Marit E Jørgensen; Marie Frimodt-Møller; Britt W Jensen; Jennifer L Baker Journal: PLoS Med Date: 2022-09-21 Impact factor: 11.613